Amedisys, a Louisiana-based home health and hospice company, plans to acquire the hospice operations of Hackensack University Medical Center in New Jersey.
Hospice of Hackensack, with annual revenues of approximately $5 million in 2010, operates one hospice agency and one eight-bed hospice inpatient unit, primarily serving the counties of Bergen and Hudson, but is licensed to provide care throughout New Jersey.
[See also: Amedisys to acquire Beacon Hospice.]
“At HUMC, our focus is always on providing the most advanced, top-quality care possible to the people we serve, either directly or by partnering with providers who share our philosophy,” said Dianne Aroh, executive vice president, chief nursing and patient care officer at HUMC. “We believe this vision is shared by Amedisys, and by completing this transaction and working together to streamline the transition of care to our patients, we will strengthen the end-of-life care being provided to our community.”
“We have worked closely with HUMC since acquiring their home health operations in 2009 to provide patients a seamless transition of care from the hospital to home. We are eager to expand this relationship to hospice services,” said William F. Borne, Amedisys’ chief executive officer.
The transaction remains subject to customary closing conditions, including state regulatory approvals. It is not expected to add materially to Amedisys’ earnings in 2011.